During the past decade, Southeastern Digestive & Liver Disease conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeastern Digestive & Liver Disease" are "Crohn's Disease" (3 trials), "Hepatitis C" (2 trials) and "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Southeastern Digestive & Liver Disease" in a lesser frequency.

Most popular intervention types in "Southeastern Digestive & Liver Disease" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "DB adalimumab 40 mg eow" (1 trials), "DB adalimumab 40 mg ew" (1 trials) and "Double-blind (DB) adalimumab placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Digestive & Liver Disease" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Digestive & Liver Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Southeastern Digestive & Liver Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Digestive & Liver Disease, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".